CalonLab

Translational Research in Tumor Microenvironment Laboratory, lead by Alexandre Calon, PhD.

#IMIM #PRBB #Cancer

Contact us: [email protected]
IG: @calonlab

[CalonLab @CalonLab]

📢 Published in @Gut_BMJ! We define CTHRC1-CAFs as a #biomarker of clinical outcome and response to #immunotherapy in MSS and MSI #colorectal #cancer.

https://t.co/2kl6t2V1p5

@mariglesiascoma @Calon_Alex @BatlleLab @ClaraMontagut @hospitaldelmar @HMar_research @IRBBarcelona

[Alexandre Calon @Calon_Alex]

📢 Our paper is out!

We define CTHRC1-CAFs as #biomarker of response to #immunotherapy in MSS and MSI #CRC

Great teamwork @CalonLab @BatlleLab @mariglesiascoma

Thanks @ContraCancerEs for their support

🔗 https://t.co/46HjvMjvXu

[HMar Research Institute @HMar_research]

🔬CTHRC1 identificat com biomarcador clau en càncer colorectal
🧬Liderat per @Calon_Alex @HMar_research i @BatlleLab @IRBBarcelona
📊Validat en ~3.000 pacients
🧪Amb @ClaraMontagut i @mariglesiascoma
👉Estudi: https://t.co/Qn9CWS2i9t
@hmarpath @CIBER_ISCIII

[Alexandre Calon @Calon_Alex]

💡Chemists, physicists, biologists, clinicians, and computational scientists — 4 teams, one vision: bringing new hope to people facing colorectal cancer.

Thanks to @FundlaCaixa / Health Research Call 2025.

@CanalUGR @uniovi_info @cnag_eu @CaixaResearch @HMar_research

[CaixaResearch @CaixaResearch]

1/ 🧬 Colorectal cancer is still one of the most frequent and deadly and many patients don't respond well to chemotherapy.

With the support of #HealthResearch, @CalonLab will investigate cells in the tumour environment to improve and personalise treatments. 👇

https://t.co/SNEmPKgwZA

[HMar Research Institute @HMar_research]

🔬 Join us at the @hmar_research-@UPFbiomed Seminar!

🗓️16/9 📌Ramon y Cajal Room

Talks by @JLinaresA @hospitaldelmar - @HMar_research & @TheAnaJanic @UPFbiomed

👉https://t.co/Xzvw8R871C

@the_prbb

[Hospital del Mar @hospitaldelmar]

La @JaneMateu_FDT beca un projecte liderat per la Dra. Sònia Segura

Mirarà de determinar el valor pronòstic de les molècules del microambient tumoral en #melanoma

#Dermatologia #PremiosJMF2025 #BecasJMF @HMar_research @CalonLab @Calon_Alex

https://t.co/fKLgEtYPAr

[Jenniffer Linares @JLinaresA]

Muchísimas gracias a @criscancer por la oportunidad de poder disfrutar del Programa CRIS Médico Traslacional 👩🏻‍⚕️

Esta ayuda será un gran impulso para seguir investigando y trabajando para mejorar la supervivencia del #mCRC

Gracias @ClaraMontagut y @HMar_research por su apoyo

[HMar Research Institute @HMar_research]

CRIS contra el #càncer premia la Dra. Jenniffer Linares

La investigadora de l'Institut de Recerca de l'Hospital del Mar ha estat guardonada amb el Programa CRIS de Talento Médico Traslacional

#TalentMAR #recerca #oncologia #DíaCienciaCRIS25 @JLinaresA

https://t.co/1xo6beR6ur

[HMar Research Institute @HMar_research]

Three researchers from the @HMar_research receive #research grants from @ContraCancerBCN

Lluís Espinosa, @JLinaresA and @ClaraMontagut lead the selected projects. @SoniaServitja participates in a study led by @IRBBarcelona

#CancerResearch #TalentMAR

https://t.co/TCxzWVXZoO

[Hospital del Mar @hospitaldelmar]

El Dr. @Calon_Alex explica la #recerca que ha permès crear #MIRO, dispositiu que replica els #tumors per estudiar l’eficàcia de la #immunoteràpia

Treball amb @IBECBarcelona i @CIPFciencia que publica @NatureComms

#oncologia #càncer #recerca

https://t.co/YtSglQk7uT

[Hospital del Mar @hospitaldelmar]

A team led by @HMar_research, @IBECBarcelona, @CIPFciencia, has developed #MIRO, a device that allows to replicate the characteristics of #tumours and their environment using patient cells

#oncologia #càncer #recerca #immunoteràpia

https://t.co/vDBTw2vPFb

[CalonLab @CalonLab]

Paper alert! 📢 With the @XavierTrepat lab, we have developed MIRO, an #invitro platform to recreate #Cancer cells interactions with their microenvironment to test new #Immunotherapy strategies.

https://t.co/yE3arQDOO3
@HMar_research @hospitaldelmar @IBECBarcelona @NatureComms

[HMar Research Institute @HMar_research]

El Dr. @Calon_Alex ha estat un dels investigadors que han participat en la jornada 'Evolution of Cancer Pharmacology', organitzada per la @SIFfarmacologia, presentant els detalls de la #recerca que porta a terme el @CalonLab

#TalentMAR #oncologia

[CalonLab @CalonLab]

It was a pleasure to participate!

[CalonLab @CalonLab]

Very proud of Dr. @JLinaresA, oncologist in our lab, for winning the Young Talent Award from @ufvmadrid and @merck_es!!

@hospitaldelmar
@HMar_research
@the_prbb

[Andres Cervantes @AndresC27622123]

The prognostic potential of CDX2 in colorectal cancer: harmonizing biology and clinical practice - Cancer Treatment Reviews https://t.co/88QpITYSRv

[Noelia Tarazona @TarazonaNoelia]

💥Just OUT: the role of CDX2 loss in CRC 🧫. 🤝A collaborative effort with @CalonLab

📌 Is the current classification of CDX2 loss appropriate?
📌 Will be possible to reverse CDX2 loss and improve patients’ prognosis?

Work supported by @fundacionmutua

https://t.co/stX4IjNCpf

[CalonLab @CalonLab]

❗️📢 Just out!

Review on the roles of CDX2 in #colorectal #cancer, where we discuss the biology and clinical relevance of CDX2 as an actionable #biomarker of #CRC.

@TarazonaNoelia @Calon_Alex @AndresC27622123
@hospitaldelmar @HMar_research @incliva_iis

https://t.co/z94dLJGmKq

[CalonLab @CalonLab]

We are #hiring!!

Fully funded #postdoc position in our lab! @Calon_Alex

Please share!

For more info:
https://t.co/GmFZr5JOjQ

#Cancer #immunotherapy #chemotherapy
#TalentMAR
@hospitaldelmar
@ContraCancerEs
@UPFbiomed
@the_prbb
@ccr_mar